ReviewArchives of pathology & laboratory medicine2019
Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.
Open access · diamondAbstract readReview
In one paragraph
Review in Archives of pathology & laboratory medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Trends and Drivers of Head and Neck Cancers in Older Adults Over 30 Years: A Population-Based Modelling Study.Risk management and healthcare policy · 2026Article
- Exploring the landscape of AI-assisted decision-making in head and neck cancer treatment: a comparative analysis of NCCN guidelines and ChatGPT responses.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024Article
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx.Head and neck pathology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 2 countries.
James S LewisFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
David J AdelsteinFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Abbas AgaimyFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Diane L CarlsonFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
William C FaquinFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Tim HelliwellFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Jos HilleFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Tony NgFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
John M NichollsFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Brian O'SullivanFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Lester D R ThompsonFrom the Departments of Otolaryngology, and Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Lewis); the Department of Otorhinolaryngology, Cleveland Clinic, Cleveland, Ohio (Dr Adelstein); the Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany (Dr Agaimy); the Department of Pathology, Cleveland Clinic Florida, Weston (Dr Carlson); the Department of Pathology, Massachusetts General Hospital, Boston (Dr Faquin); the Department of Cellular Pathology, University of Liverpool, Liverpool, United Kingdom (Dr Helliwell); the Department of Oral & Maxillofacial Pathology, University of the Western Cape & Tygerberg Laboratories, Cape Town, South Africa (Dr Hille); the Department of Pathology, Vancouver General Hospital, and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Dr Ng); the Department of Pathology, Queen Mary Hospital, Hong Kong (Dr Nicholls); the Radiation Medicine Program, Princess Margaret Hospital, Toronto, Ontario, Canada (Dr O'Sullivan); and the Department of Pathology, Woodland Hills Medical Center, Woodland Hills, California (Dr Thompson).
Cleveland Clinic · USVanderbilt University Medical Center · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Erlangen · DE
Funding
Strategies to Overcome Immune Resistance in Head and Neck CancersP01CA240239 · NCI · YALE UNIVERSITY · PI MEMPEL, THORSTEN ROMAN · 2019 to 2023
$8.4MNCI NIH HHS P01 CA240239
Abstract
The International Collaboration on Cancer Reporting was established to internationally unify and standardize the pathologic reporting of cancers based on collected evidence, as well as to allow systematic data collection across institutions and countries to guide cancer care in the future. An expert panel was convened to identify the minimum data set of elements that should be included in cancer reporting from tumors of the nasopharynx and oropharynx. Specifically, there has been a significant change in practice as a result of identifying oncogenic viruses, including human papillomavirus and Epstein-Barr virus, because they preferentially affect the oropharynx and nasopharynx, respectively. For these anatomic sites, when viral association is taken into account, usually reported elements of in situ versus invasive tumor, depth of invasion, and degree of differentiation are no longer applicable. Thus, guidance about human papillomavirus testing in oropharyngeal carcinomas and Epstein-Barr virus testing in nasopharyngeal carcinomas is highlighted. Further, the clinical and the pathologic differences in staging as proposed by the 8th edition of the Union for International Cancer Control are incorporated into the discussion, pointing out several areas of continued study and further elaboration. A summary of the International Collaboration on Cancer Reporting guidelines for oropharyngeal and nasopharyngeal carcinomas is presented, along with discussion of the salient evidence and practical issues.
Indexed as
Datasets as TopicPractice Guidelines as TopicCarcinomaHumansNasopharyngeal NeoplasmsOropharyngeal NeoplasmsPathology, Clinical
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.